HCW Biologics is trading 6.96% down at $3.34 in after-hours trading, possibly reflecting profit-taking following a sharp multi-session rally.
- No company-specific announcement dated August 31, 2026, was identified.
- The latest company releases concerned second-quarter results on August 14 and immunotherapy research on August 25.
- Shares gained 17.41% on August 27 and 8.20% on August 28, while the broader market was modestly weaker.